# Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control

> **NCT05477875** · PHASE2 · COMPLETED · sponsor: **University of Florida** · enrollment: 35 (actual)

## Conditions studied

- Photorefractive Keratectomy
- Myopia
- Hyperopia

## Interventions

- **DRUG:** oral cannabinoid
- **COMBINATION_PRODUCT:** oral codeine/acetaminophen

## Key facts

- **NCT ID:** NCT05477875
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-01
- **Primary completion:** 2025-01-22
- **Final completion:** 2025-01-22
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05477875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05477875, "Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05477875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*